These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities. Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597 [TBL] [Abstract][Full Text] [Related]
8. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Mailleux AA; Overholtzer M; Schmelzle T; Bouillet P; Strasser A; Brugge JS Dev Cell; 2007 Feb; 12(2):221-34. PubMed ID: 17276340 [TBL] [Abstract][Full Text] [Related]
9. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation. Anderson LR; Sutherland RL; Butt AJ Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545 [TBL] [Abstract][Full Text] [Related]
10. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells. Uehara N; Matsuoka Y; Tsubura A Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228 [TBL] [Abstract][Full Text] [Related]
11. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance. Whelan KA; Schwab LP; Karakashev SV; Franchetti L; Johannes GJ; Seagroves TN; Reginato MJ J Biol Chem; 2013 May; 288(22):15865-77. PubMed ID: 23585570 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928 [TBL] [Abstract][Full Text] [Related]
14. Role of Bim in the survival pathway induced by Raf in epithelial cells. Marani M; Hancock D; Lopes R; Tenev T; Downward J; Lemoine NR Oncogene; 2004 Apr; 23(14):2431-41. PubMed ID: 14676826 [TBL] [Abstract][Full Text] [Related]
15. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Vitolo MI; Weiss MB; Szmacinski M; Tahir K; Waldman T; Park BH; Martin SS; Weber DJ; Bachman KE Cancer Res; 2009 Nov; 69(21):8275-83. PubMed ID: 19843859 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation. Iwakiri D; Minamitani T; Samanta M J Virol; 2013 Jul; 87(14):8227-34. PubMed ID: 23698301 [TBL] [Abstract][Full Text] [Related]
17. Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells. Parsons MJ; Patel P; Brat DJ; Colbert L; Vertino PM Cancer Res; 2009 Mar; 69(5):1706-11. PubMed ID: 19223547 [TBL] [Abstract][Full Text] [Related]
18. BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors. Fukazawa H; Noguchi K; Masumi A; Murakami Y; Uehara Y Mol Cancer Ther; 2004 Oct; 3(10):1281-8. PubMed ID: 15486195 [TBL] [Abstract][Full Text] [Related]